ONO 8815Ly

Drug Profile

ONO 8815Ly

Alternative Names: ONO 8815

Latest Information Update: 26 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Class Small molecules
  • Mechanism of Action Dinoprostone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Preterm labour

Most Recent Events

  • 05 Mar 2004 A study has been added to the Women's Health therapeutic trials section
  • 31 Mar 2002 Clinical trials in Preterm labour in Sweden (IV-injection)
  • 31 Mar 2001 Phase-I clinical trials for Preterm labour in Japan (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top